FDA Inspection
VitalantVitalant – FDA Inspection, Feb 23, 2026
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on February 23, 2026, issued by the Denver District Office, covering biologics.
View Company Profile
ID · 1a9a8191-f0d4-490f-8d79-ec3f649af69f
Inspection Facts
- Inspection number
- 1304170
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 26, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 2, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 11, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 25, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1172505 - 2022-06-09
- FDA Inspection 1040747 - 2018-01-26
- FDA Inspection 981946 - 2016-06-02
- FDA Inspection 858390 - 2013-12-11
- FDA Inspection 759960 - 2011-10-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.